Abstract Background Group B Streptococcus (GBS) remains a leading cause of neonatal
sepsis in high-income contexts, despite declines due to intrapartum antibiotic prophylaxis …

Background Despite widespread use of intrapartum antibiotic prophylaxis, group B
streptococcus remains a leading cause of morbidity and mortality in infants in Europe, the …

Streptococcus agalactiae (group B streptococcus (GBS)), remains the leading cause of
neonatal sepsis and meningitis in many countries and an important cause of disease in …

Methods: We searched the literature for studies from developing countries reporting etiology
of community-acquired infections (sepsis, pneumonia, meningitis) published since 1980 …

Objective To review the aetiology and antibiotic resistance patterns of community-acquired
sepsis in developing countries in infants where no clear focus of infection is clinically …

Global neonatal mortality continues to be unacceptably high, with 4 million neonatal deaths
each year. 1 Of these, 99% occur in the developing world, with South Asia and sub-Saharan …

Background 99% of the approximate 1 million annual neonatal deaths from life-threatening
invasive bacterial infections occur in developing countries, at least 50% of which are from …

Abstract Group B Streptococcus (GBS) is a leading cause of neonatal sepsis in developed
countries. Its burden in the developing world is less clear. Studies reporting neonatal GBS …

The spectrum of bacteria which cause neonatal sepsis varies in different parts of the world.
Antibiotic resistance is an increasing problem of these bacteria. The aim of this study was to …

An estimated one million newborns die from infections in developing countries. Despite the
huge burden, high-quality data from community-based epidemiologic studies on etiology …